Tianyancha: OpenAI’s subsidiaries “OPENAI GPT-5” and “GPT-5” trademarks are both under rejection review
According to ChainCatcher, information from the Tianyancha app shows that OpenAI, Inc. has applied to register two "OPENAI GPT-5" trademarks, classified under website services and scientific instruments. Both trademark applications are currently awaiting review after rejection.
In addition, OpenAI OpCo, LLC has also applied to register two "GPT-5" trademarks, also classified under website services and scientific instruments. Both trademark applications are currently under review following rejection. (Jiemian)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound: Wider trading range expected against US Dollar – UOB

British Pound holds gains as UK GDP and Industrial Production beat expectations

UBS: Resumes coverage of Regeneron Pharmaceuticals (REGN.US) with a "Buy" rating; potential of blockbuster drug Dupixent underestimated
UBS has resumed coverage of Regeneron Pharmaceuticals (REGN.US) with a "Buy" rating and a target price of $978.
IMF sounds the alarm: Energy shocks and rising US Treasury yields pose spillover risks, Asia’s growth may slow to 4.4% next year
The IMF has lowered its growth forecast for Asia to 4.4% for next year, warning of three major risks: energy shocks, a correction in the AI boom, and rising global yields. The IMF also urged central banks to focus on price stability and avoid broad-based fuel subsidies.

